The groundbreaking approach of the medication represents a exciting development in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide981332.bloggazza.com/40739553/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment